Evidence map›Paper›PMID 31953941›Full record

ArticleThe Journal of antimicrobial chemotherapy2020

Klebsiella pneumoniae ST307 with OXA-181: threat of a high-risk clone and promiscuous plasmid in a resource-constrained healthcare setting.

K A Strydom, L Chen, M M Kock, A C Stoltz, G Peirano, D B Nobrega, M Lowe, M M Ehlers, N M Mbelle, B N Kreiswirth and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of antimicrobial chemotherapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Observational
  3. Genomic landscape ofApplied and environmental microbiology · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Infection and immunity · 2025
    Review
  9. Article
  10. Rapidly spreadingJournal of clinical microbiology · 2025
    Review
  11. Review
  12. Article
  13. Article
  14. Klebsiella pneumoniae with carbapenemases: high prevalence of sequence type 307 with blaEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2024
    Article
  15. Article
  16. Antimicrobial agents and chemotherapy · 2024
    Review
  17. Review
  18. Carbapenemase-ProducingAntibiotics (Basel, Switzerland) · 2023
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 3 countries.

K A StrydomUniversity of Pretoria, Pretoria, Gauteng, South Africa.
L ChenHackensack Meridian Health, Nutley, NJ, USA.
M M KockUniversity of Pretoria, Pretoria, Gauteng, South Africa.
A C StoltzUniversity of Pretoria, Pretoria, Gauteng, South Africa.
G PeiranoAlberta Public Laboratories, Calgary, Alberta, Canada.
D B NobregaFaculty of Veterinary Medicine, Calgary, Alberta, Canada and University of Calgary Calgary, Alberta, Canada.
M LoweUniversity of Pretoria, Pretoria, Gauteng, South Africa.
M M EhlersUniversity of Pretoria, Pretoria, Gauteng, South Africa.
N M MbelleUniversity of Pretoria, Pretoria, Gauteng, South Africa.
B N KreiswirthHackensack Meridian Health, Nutley, NJ, USA.
J D D PitoutUniversity of Pretoria, Pretoria, Gauteng, South Africa.
National Health Laboratory Service · ZAHackensack Meridian Health · USUniversity of Pretoria · ZAUniversity of Calgary · CA

Funding

The molecular basis of the epidemic blaKPC gene KlebsiellaR01AI090155 · NIAID · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI KREISWIRTH, BARRY NEAL · 2011 to 2021
$7.2M
NIAID NIH HHS R01 AI090155
6 · The paper itself

Abstract

introductionKlebsiella pneumoniae with OXA-48-like enzymes were introduced into Tshwane Tertiary Hospital (TTH) (Pretoria, South Africa) during September 2015, causing nosocomial outbreaks.

methodsPCR methodologies and WGS were used to characterize K. pneumoniae with carbapenemases (n = 124) from TTH (July 2015-December 2016).

resultsPCR was used to track K. pneumoniae ST307 with OXA-181 among 60% of carbapenemase-positive isolates in different wards/units over time and showed the transmission of IncX3 plasmids to other K. pneumoniae clones. WGS identified different ST307 clades: 307_OXA181 (consisting of two lineages, A and B) with OXA-181 on IncX3 plasmids (named p72_X3_OXA181) and clade 307_VIM with VIM-1 on IncFII plasmids. Clade 307_OXA181 lineage B was responsible for the rapid increase and transmission of OXA-181 K. pneumoniae in various wards/units throughout TTH, while the numbers of clade 307_OXA181 lineage A and clade 307_VIM remained low. Separate outbreaks were due to K. pneumoniae ST17 and ST29 with p72_X3_OXA181 plasmids.

conclusionsThe high-risk clone K. pneumoniae ST307 with OXA-181 rapidly spread to different wards/units despite infection and prevention measures. ST307 clades and lineages seemingly acted differently in outbreak situations. This study also highlighted the threat of promiscuous plasmids such as p72_X3_OXA181.

Indexed as

Klebsiella InfectionsKlebsiella pneumoniaeBacterial Proteinsbeta-LactamasesClone CellsDelivery of Health CareHumansPlasmidsSouth AfricaBacterial Proteinsbeta-Lactamases

Identifiers

PMID31953941
PMCPMC7069492
OpenAlexW3000710932

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.